Shanghai Operation Robot Co., Ltd. ("Aopeng") is an innovative leader in endovascular interventional robotic surgery and AI clinical innovation.
The Core Team
Aopeng’s core team is composed of excellent educated talents in global R&D, manufacturing, commercialization, and marketing from multinational companies. We are committed to providing you excellent environment with engagement, innovation, and high-quality culture. Aopeng has nearly one hundred patents and PCT applications.
ALLVAS® Endovascular Interventional Robot
Laparoscopic Minimally Invasive Surgical Robot
ESD Robot & ERCP Robot
Aopeng Orthopedic Surgical Robot
AI Medical Imaging Products
Shanghai Operation Robot announced the first Robot-assisted human clinical trial of biliary stent placement surgery
In less than a month, the World Conference on Artificial Intelligence 2022 will officially open. This reporter went to Shanghai artificial intelligence enterprises to understand how the industry guide is to break the barriers and bottlenecks of core technology, reflecting the power of AI.
On August 1, 2021, ALLVAS™, an endovascular interventional surgery robot independently developed by Shanghai Operation Robot Co., Ltd. successfully completed the first human clinical study of interventional surgery with covered aortic stents.